A novel immunotherapeutic approach improved outcomes for patients with advanced bladder cancer, according to a recent study.
With some training and selective food reinforcement, pigeons performed as well as humans in categorizing digitized slides and mammograms showing benign and malignant human breast tissue.
The impact on PSA screening and prostate cancer incidence before and after the 2012 USPSTF screening recommendations were examined in two recent studies.
Receipt of the 21-gene recurrence score assay (RS) impacts breast cancer treatment and health care costs.
The incidence of febrile neutropenia was significantly higher among patients who received pegfilgrastim prophylaxis on the same day.
Use of estrogen with progestin increases the risk of estrogen receptor (ER)-positive breast cancer in African American women.
Women who have ovarian cancer often develop ascites, a buildup of fluids in the abdomen. Researchers have found that ascites can be reduced with minimal side effects through inhibition of the colony-stimulating-factor-1 receptor (CSF1R).
Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical Cancer
Both the stage of cervical cancer at diagnosis and the receipt of fertility-sparing treatment among young women age 21 to 25 years, but not among women age 26 to 34 years, is associated with the Affordable Care Act Dependent Coverage Expansion provision.
A new test is better at detecting aggressive prostate cancer than measuring PSA levels. The new test discovers aggressive cancer earlier and reduces the number of false positive tests and unnecessary biopsies.
An international team of scientists has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions to malignant skin cancer.
New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good health care structures in place.
International Experts Call for Investigations Into Long-Term Management Options for Select Patients With Advanced Breast Cancer
International experts have called for a clinical trial to investigate the best ways for identifying and treating a small but important group of patients with advanced breast cancer who can survive for long periods without their disease progressing.
Patients With Advanced Breast Cancer Address an International Conference About Misleading Disease-Specific Messages
Patients with advanced breast cancer spoke out about the damaging messages some organizations issue about advanced breast cancer. They need to be identified and educated to change the way they talk about the disease.
The more children a woman has or whether she has undergone tubal ligation lowers her risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 NCRI Cancer Conference.
A widely available, inexpensive blood test can predict outcomes and guide treatment in pancreatic cancer; however, only 1 in 5 US patients with the disease have the blood test.
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- New Blood Test Improves Screening for Prostate Cancer
- Nanoliposomal Irinotecan Extends Survival in Metastatic Pancreatic Cancer
- Blood Sample Offers a New Way of Detecting Cancer
- International Study Charts Genetic Trajectory for Melanoma
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- FDA Approves Elotuzumab for Multiple Myeloma Combination Therapy
- Investigational Immunotherapeutic Approach Increased Survival in Patients With Bladder Cancer
- Researchers Show That Pigeons Are Adept at Interpreting Radiologic Diagnostic Images
- Rates of PSA Screening and Early Stage Prostate Cancer Are Declining
- Use of Genomic Testing in Breast Cancer Has Greater Impact on Treatment, Costs
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|